ClinicalTrials.gg
CompletedNCT01420406Updated Sep 12, 2012

Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status

An interventional study of 0 mg retinol activity equivalents and 12 mg of BC in Vitamin A Deficiency, sponsored by USDA, Western Human Nutrition Research Center. Completed at 1 site in Bangladesh. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-09-12.

Sponsored by USDA, Western Human Nutrition Research Center · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The study will assess the relative bioavailability and bioefficacy of cryptoxanthin (CX) and beta-carotene (BC) from food sources for increasing breast milk carotenoid and retinol concentrations in lactating Bangladeshi women.

Read the detailed description

The specific aim is to compare the effects of orange-fleshed sweet potatoes and tangerines compared to white-fleshed sweet potatoes and vitamin A as retinyl palmitate on blood and breast milk cryptoxanthin (CX), beta-carotene (BC), and vitamin A (VA) concentrations by randomly assigning lactating Bangladeshi women to one of four treatment groups for 6 days/week for 3 weeks.

The investigators will also compare the relative vitamin A (VA) value of BC and CX from food sources by comparing the mean change in breast milk retinol concentrations of the groups that receive tangerines (CX) or orange-fleshed sweet potatoes (BC) with the mean change in breast milk retinol of the group that receives retinyl palmitate.

02

Conditions studied

  • Vitamin A Deficiency

Keywords

  • lactation
  • cryptoxanthin
  • beta-carotene
  • vitamin A
03

In context

Vitamin A Deficiency

67 studies on the registry are indexed under Vitamin A Deficiency; 7 are open to participants now.

This study's enrollment of 140 is below the median of 200 across 49 interventional studies indexed under Vitamin A Deficiency.

Browse Vitamin A Deficiency studies →

Lead sponsor

USDA, Western Human Nutrition Research Center is the lead sponsor of 54 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy women in Dhaka, Bangladesh
  • Lactating women in their 2nd or 3rd month of lactation who are planning to breast-feed at least 6 months
  • Breast-feeding only one infant
  • Age range 18 to 45 years
  • Not pregnant
  • Serum retinol concentrations >0.70 umol/L and \<1.10 umol/L
  • Normal concentrations of CRP (\<10 mg/L)
  • At least one arm vein deemed adequate for blood collection, as evaluated by a screening nurse.
  • Willing to consume the test foods daily 6 d/wk for one month

Exclusion criteria

Exclusion Criteria:

  • Health status is not compatible with the inclusion criteria, such as screening blood chemistries indicative of vitamin A deficiency.
  • Severe anemia ( \<9 mg/dL)
  • Current pregnancy
  • Must not have known allergy to citrus fruit (tangerines or mandarin oranges) or sweet potatoes
  • Must have no obvious psychological or sociological problems-such as alcoholism, drug abuse, or severe and acute mental illness that would influence their ability to sign an inform consent agreement or to participate in study duties and activities
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (actual)

Study arms

  • Placebo comparator
    0 mg retinol

    0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule

    Other: 0 mg retinol activity equivalents

  • Experimental
    12 mg BC

    12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule.

    Other: 12 mg of BC

  • Experimental
    6 mg of CX

    6 mg of CX as tangerines and a corn oil capsule

    Other: 6 mg of CX

  • Experimental
    1.0 mg RAE

    1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes

    Other: 1.0 mg RAE

Interventions

  • Other0 mg retinol activity equivalents

    0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule

  • Other12 mg of BC

    12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule

  • Other6 mg of CX

    6 mg of CX as tangerines and a corn oil capsule

  • Other1.0 mg RAE

    1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes

06

What researchers measure

Primary outcomes

  1. Change in carotenoids in serum and breast milk

    We will measure serum and breast milk beta-carotene, beta-cryptoxanthin, other carotenoids, and vitamins A and E.

    Time frame: 1 and 3 weeks

Secondary outcomes

  1. Change in Dark adaptation

    Dark adaptation will be measured by the pupillary threshold (PT) test on the first and 3rd weeks of the study.

    Time frame: 1 and 3 weeks

07

Study locations

1 site
  • International Centre for Diarrhoeal Disease Research
    Dhaka, Bangladesh
08

References and documents

Publications

  • Turner T, Burri BJ, Jamil KM, Jamil M. The effects of daily consumption of beta-cryptoxanthin-rich tangerines and beta-carotene-rich sweet potatoes on vitamin A and carotenoid concentrations in plasma and breast milk of Bangladeshi women with low vitamin A status in a randomized controlled trial. Am J Clin Nutr. 2013 Nov;98(5):1200-8. doi: 10.3945/ajcn.113.058180. Epub 2013 Sep 4. PubMed 24004891 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2010, a primary completion of May 2011 and a completion of Jun 2012. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2011
First posted
Aug 19, 2011
Start
Jun 2010
Primary completionActual
May 2011
CompletionActual
Jun 2012
Last update
Sep 12, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01420406
Lead sponsor
USDA, Western Human Nutrition Research Center
Responsible party
Sponsor
First posted
Aug 19, 2011
Start date
Jun 2010
Primary completion
May 2011
Completion
Jun 2012
Last update
Sep 12, 2012

Study contacts

Betty J Burri, PhD
principal investigator · WHNRC

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion